| Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in … MV Dieci, N Radosevic-Robin, S Fineberg, G Van den Eynden, N Ternes, ... Seminars in cancer biology 52, 16-25, 2018 | 415* | 2018 |
| Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis EV Lemos, FP de La Hoz, TR Einarson, WF McGhan, E Quevedo, ... Clinical Microbiology and Infection 20 (5), 416-423, 2014 | 328 | 2014 |
| The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer CA Castaneda, H Cortes-Funes, HL Gomez, EM Ciruelos Cancer and Metastasis Reviews 29, 751-759, 2010 | 233 | 2010 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 166 | 2020 |
| Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy SJ Luen, R Salgado, MV Dieci, A Vingiani, G Curigliano, RE Gould, ... Annals of Oncology 30 (2), 236-242, 2019 | 166 | 2019 |
| The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ... NPJ breast cancer 7 (1), 150, 2021 | 138 | 2021 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 130 | 2020 |
| Infecciones del tracto urinario bajo en adultos y embarazadas: consenso para el manejo empírico E Martínez, J Osorio, J Delgado, GE Esparza, G Motoa, VM Blanco, ... Infectio 17 (3), 122-135, 2013 | 126 | 2013 |
| Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ breast cancer 6 (1), 16, 2020 | 119 | 2020 |
| Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI … C Saura, D Hlauschek, M Oliveira, D Zardavas, A Jallitsch-Halper, ... The Lancet Oncology 20 (9), 1226-1238, 2019 | 98 | 2019 |
| Interobserver agreement between pathologists assessing tumor-infiltrating lymphocytes (TILs) in breast cancer using methodology proposed by the International TILs Working Group SK Swisher, Y Wu, CA Castaneda, GR Lyons, F Yang, C Tapia, X Wang, ... Annals of surgical oncology 23, 2242-2248, 2016 | 98 | 2016 |
| Distribution of tumor-infiltrating immune cells in glioblastoma E Orrego, CA Castaneda, M Castillo, LA Bernabe, S Casavilca, ... CNS oncology 7 (4), CNS21, 2018 | 63 | 2018 |
| Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy CA Castaneda, E Mittendorf, S Casavilca, Y Wu, M Castillo, P Arboleda, ... World journal of clinical oncology 7 (5), 387, 2016 | 60 | 2016 |
| Combined label-free quantitative proteomics and microRNA expression analysis of breast cancer unravel molecular differences with clinical implications A Gámez-Pozo, J Berges-Soria, JM Arevalillo, P Nanni, R López-Vacas, ... Cancer research 75 (11), 2243-2253, 2015 | 59 | 2015 |
| Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America CA Castaneda, C Torres-Cabala, M Castillo, V Villegas, S Casavilca, ... Clinical and Translational Oncology 19, 1478-1488, 2017 | 54 | 2017 |
| HLA DQA1* 0501 and DQB1* 02 in Cuban celiac patients A Cintado, L Sorell, JA Galván, L Martínez, C Castañeda, T Fragoso, ... Human immunology 67 (8), 639-642, 2006 | 54 | 2006 |
| Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis C Castaneda, E Garcia, M Santa Cruz, M Fernandez, P Monterrey Rev Mex Pueric Pediatr 2, 12-16, 1995 | 48 | 1995 |
| The implementation of the Plan Esperanza and response to the imPACT Review T Vidaurre, C Santos, H Gómez, G Sarria, E Amorin, M López, ... The Lancet Oncology 18 (10), e595-e606, 2017 | 47 | 2017 |
| Clinical trial with a preparation based on propolis" propolisina" in human giardiasis C Miyares, I Hollands, C Castaneda, T Gonzalez, T Fragoso, R Curras, ... Acta Gastroenterologica Latinoamericana 18 (3), 195-201, 1988 | 42 | 1988 |
| Coeliac disease in Cuban children. EB Rabassa, E Sagaró, T Fragoso, C Castañeda, B Gra Archives of Disease in Childhood 56 (2), 128-131, 1981 | 42 | 1981 |
